Immune Biosolutions
PrivateLast Round
Series A
Mar 16, 2021
Total Funding Raised
$18.42M
Company Overview
Immune Biosolutions is a biotechnology company that develops clinical-grade antibodies for therapeutic and diagnostic applications in areas such as infectious diseases and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immune Biosolutions Comparables
Compare Immune Biosolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creative Biolabs | 84% | |
| OmniAb Inc. | 78% | |
| Isogenica | 76% |
Immune Biosolutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 16, 2021 | ||||
| Debt | May 31, 2019 | ||||
| Grant | Jun 12, 2018 | ||||
| Seed | Apr 19, 2017 |
Key People
Founding team and executive leadership
Immune Biosolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Research Society | Grant |
| Consortium Québécois sur la découverte du médicament | Grant |
| Canada Economic Development for Quebec Regions | Debt |
| AmorChem | Series A, Seed |
| Government of Canada | Series A |
| Mitacs | Grant |
| Accélérateur de création d'entreprises technologiques | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased by 33% MoM.
- Nov 7, 2025
Monthly visitors increased 221% MoM.
Immune Biosolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Immune Biosolutions's valuation, stock price, and market status.
Is Immune Biosolutions a public or private company?
Immune Biosolutions is a private company.
What is the current stock price of Immune Biosolutions?
Immune Biosolutions is a private company with no public stock price. No recent secondary market data is available.
How much is Immune Biosolutions worth (valuation)?
Valuation information for Immune Biosolutions is not publicly available.
Can I buy Immune Biosolutions stock?
Immune Biosolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Immune Biosolutions's last funding round?
Immune Biosolutions's most recent funding round was Series A on March 16, 2021.
Who are the main investors in Immune Biosolutions?
Key investors in Immune Biosolutions include Consortium Québécois sur la découverte du médicament, Canada Economic Development for Quebec Regions.
Will Immune Biosolutions IPO soon?
No public IPO plans have been announced for Immune Biosolutions.
How can I track Immune Biosolutions secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Immune Biosolutions's secondary market activity and sign up for updates.